Google News – FDA (biotech/pharma) External News
Biotechnology Articles
Google News – FDA (biotech/pharma) External News
Piramal Pharma Share Price Gains Over 3% As US FDA Closes Inspection - NDTV Profit
Google News – FDA (biotech/pharma) External News
Piramal Pharma Sellersville Site Clears US FDA Inspection with 0 Observations Reported - Sahi
Google News – FDA (biotech/pharma) External News
Piramal Pharma shares rise 4% on successful closure of US FDA inspection - Business Standard
Google News – Clinical Trials External News
Matica Bio Partners with VaxDome to Advance Novel Intranasal Antiviral Vaccine Platform into Clinical Trials - BioPharma APAC
Google News – Clinical Trials External News
FATE Stock Jumps 6% As FDA Greenlights Moving Cell Therapy To Clinical Trials - Stocktwits
Google News – Clinical Trials External News
The Fentanyl Vaccine Is Real. The Evidence Strategy Isn’t. - The Clinical Trial Vanguard
Google News – Clinical Trials External News
China’s Ascent in Biotech Rousts U.S. Venture Capitalists to Adapt - WSJ
Google News – Clinical Trials External News
GSK cuts losses on $700M upfront Alzheimer’s collab with Alector following 2 clinical failures - Fierce Biotech
Google News – Pharmaceuticals External News
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Globe and Mail
Google News – Pharmaceuticals External News
Invesco Pharmaceuticals ETF vs State Street Biotech ETF: Which Fund Is the Better Buy in 2026? - The Motley Fool
Google News – Pharmaceuticals External News
Is Regeneron Pharmaceuticals, Inc. (REGN) Stock Still a Biotech Leader After Analyst Price Target Cut? - Yahoo Finance
Google News – Biopharma External News
Teva and Polpharma Biologics Ink Global Biosimilar Agreement - Contract Pharma
Google News – Biopharma External News
WuXi Biologics Drug Substance Manufacturing Facility Passes FDA Pre-License Inspection - Contract Pharma
Google News – Biopharma External News